4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Meningococcal Meningitis: new trials by email Literature Review of Meningococcal Meningitis trials Research Report on Meningococcal Meningitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Meningitis, Meningococcal Meningitis | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 1311 | 2016-07-21 | 2022-04-25 |
| Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine - Meningitis, Meningococcal Meningitis | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 110 | 2015-12-01 | 2016-11-07 |
| Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate - Meningitis, Meningococcal Meningitis | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 60 | 2015-10-20 | 2017-11-06 |
| A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents Placebo + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine, MenACWY-CRM Conjugate Vaccine + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine - Meningococcal Meningitis | Phase 4 | Completed | Novartis | 801 | 2011-09-01 | 2014-02-14 |
Meningitis (4) · Meningitis, Meningococcal (4) · Meningococcal Infections (3) · Tetanus (1) · Whooping Cough (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Central Nervous System Bacterial Infections (4) · Central Nervous System Diseases (4) · Central Nervous System Infections (4) · Gram-Negative Bacterial Infections (4) · Infections (4) · Meningitis, Bacterial (4) · Neisseriaceae Infections (4) · Nervous System Diseases (4) · Neuroinflammatory Diseases (4) · Bordetella Infections (1) · Clostridium Infections (1) · Gram-Positive Bacterial Infections (1) · Meningococcal Infections (1)
Sanofi Pasteur, a Sanofi Company (3) · Novartis (1)
United States (2) · Italy (1) · Japan (1) · South Korea (1)